RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes

NCT00809185 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: everolimus
OTHER: laboratory biomarker analysis
PROCEDURE: Bone marrow aspirate/biopsy

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]